High serum CD30 levels correlated with advanced stage, B symptoms, tumor bulkiness, and treatment failure53 suggesting sCD30 plays a crucial role by mediating cross‐talk in the HL tumor microenvironment. The gene discussed is TNFRSF8; the disease is Hodgkins lymphoma.